Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis

Susan L. Greenspan, Steven T. Harris, Henry Bone, Paul D. Miller, Eric Orwoll, Nelson B. Watts, Clifford J. Rosen

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Osteoporosis affects more than 28 million Americans. With the advent of accessible and affordable diagnostic studies, awareness and recognition of this disease by patients and clinicians are growing. Osteoporotic fractures of the spine and hip are costly and associated with significant morbidity and mortality. Over the past decade, a surge of new antiosteoporotic drugs have been labeled or are awaiting labeling by the U.S. Food and Drug Administration. One class of agents used to treat osteoporosis is the bisphosphonates, which inhibit bone resorption, cause an increase in bone mineral density and reduce the risk of future fractures caused by aging, estrogen deficiency and corticosteroid use. Overall, bisphosphonates have been shown to have a strong safety and tolerability profile.

Original languageEnglish (US)
Pages (from-to)2731-2736
Number of pages6
JournalAmerican Family Physician
Volume61
Issue number9
StatePublished - May 1 2000

Fingerprint

Diphosphonates
Osteoporosis
Safety
Osteoporotic Fractures
United States Food and Drug Administration
Bone Resorption
Bone Density
Hip
Adrenal Cortex Hormones
Estrogens
Spine
Morbidity
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Greenspan, S. L., Harris, S. T., Bone, H., Miller, P. D., Orwoll, E., Watts, N. B., & Rosen, C. J. (2000). Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis. American Family Physician, 61(9), 2731-2736.

Bisphosphonates : Safety and efficacy in the treatment and prevention of osteoporosis. / Greenspan, Susan L.; Harris, Steven T.; Bone, Henry; Miller, Paul D.; Orwoll, Eric; Watts, Nelson B.; Rosen, Clifford J.

In: American Family Physician, Vol. 61, No. 9, 01.05.2000, p. 2731-2736.

Research output: Contribution to journalArticle

Greenspan, SL, Harris, ST, Bone, H, Miller, PD, Orwoll, E, Watts, NB & Rosen, CJ 2000, 'Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis', American Family Physician, vol. 61, no. 9, pp. 2731-2736.
Greenspan SL, Harris ST, Bone H, Miller PD, Orwoll E, Watts NB et al. Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis. American Family Physician. 2000 May 1;61(9):2731-2736.
Greenspan, Susan L. ; Harris, Steven T. ; Bone, Henry ; Miller, Paul D. ; Orwoll, Eric ; Watts, Nelson B. ; Rosen, Clifford J. / Bisphosphonates : Safety and efficacy in the treatment and prevention of osteoporosis. In: American Family Physician. 2000 ; Vol. 61, No. 9. pp. 2731-2736.
@article{bcd2460352cd4194b3acee37f267f8f3,
title = "Bisphosphonates: Safety and efficacy in the treatment and prevention of osteoporosis",
abstract = "Osteoporosis affects more than 28 million Americans. With the advent of accessible and affordable diagnostic studies, awareness and recognition of this disease by patients and clinicians are growing. Osteoporotic fractures of the spine and hip are costly and associated with significant morbidity and mortality. Over the past decade, a surge of new antiosteoporotic drugs have been labeled or are awaiting labeling by the U.S. Food and Drug Administration. One class of agents used to treat osteoporosis is the bisphosphonates, which inhibit bone resorption, cause an increase in bone mineral density and reduce the risk of future fractures caused by aging, estrogen deficiency and corticosteroid use. Overall, bisphosphonates have been shown to have a strong safety and tolerability profile.",
author = "Greenspan, {Susan L.} and Harris, {Steven T.} and Henry Bone and Miller, {Paul D.} and Eric Orwoll and Watts, {Nelson B.} and Rosen, {Clifford J.}",
year = "2000",
month = "5",
day = "1",
language = "English (US)",
volume = "61",
pages = "2731--2736",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "9",

}

TY - JOUR

T1 - Bisphosphonates

T2 - Safety and efficacy in the treatment and prevention of osteoporosis

AU - Greenspan, Susan L.

AU - Harris, Steven T.

AU - Bone, Henry

AU - Miller, Paul D.

AU - Orwoll, Eric

AU - Watts, Nelson B.

AU - Rosen, Clifford J.

PY - 2000/5/1

Y1 - 2000/5/1

N2 - Osteoporosis affects more than 28 million Americans. With the advent of accessible and affordable diagnostic studies, awareness and recognition of this disease by patients and clinicians are growing. Osteoporotic fractures of the spine and hip are costly and associated with significant morbidity and mortality. Over the past decade, a surge of new antiosteoporotic drugs have been labeled or are awaiting labeling by the U.S. Food and Drug Administration. One class of agents used to treat osteoporosis is the bisphosphonates, which inhibit bone resorption, cause an increase in bone mineral density and reduce the risk of future fractures caused by aging, estrogen deficiency and corticosteroid use. Overall, bisphosphonates have been shown to have a strong safety and tolerability profile.

AB - Osteoporosis affects more than 28 million Americans. With the advent of accessible and affordable diagnostic studies, awareness and recognition of this disease by patients and clinicians are growing. Osteoporotic fractures of the spine and hip are costly and associated with significant morbidity and mortality. Over the past decade, a surge of new antiosteoporotic drugs have been labeled or are awaiting labeling by the U.S. Food and Drug Administration. One class of agents used to treat osteoporosis is the bisphosphonates, which inhibit bone resorption, cause an increase in bone mineral density and reduce the risk of future fractures caused by aging, estrogen deficiency and corticosteroid use. Overall, bisphosphonates have been shown to have a strong safety and tolerability profile.

UR - http://www.scopus.com/inward/record.url?scp=0034192970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034192970&partnerID=8YFLogxK

M3 - Article

C2 - 10821153

AN - SCOPUS:0034192970

VL - 61

SP - 2731

EP - 2736

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 9

ER -